- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02759900
Using a Cold Atmospheric Plasma Device to Treat Skin Disorders
April 10, 2022 updated by: The Skin Center Dermatology Group
This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of skin disorders
Study Overview
Status
Recruiting
Conditions
Detailed Description
The study uses non-thermal atmospheric pressure plasma to treat target conditions.
The patients are monitored at set intervals for efficacy and adverse effects using investigator's assessment and imaging techniques
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New City, New York, United States, 10956
- Recruiting
- The Skin Center Dermatology Group
-
Contact:
- Peter C Friedman, MD, PhD
- Phone Number: 845-352-0500
- Email: pbc9@columbia.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnoses of target conditions
- ability to complete study protocol
Exclusion Criteria:
- based on specific condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Non-thermal atmospheric plasma treatment
Device treatment
|
Non-thermal, atmospheric plasma treatment of affected area or lesions using a nanosecond dielectric barrier discharge plasma device
|
Experimental: Indirect non-thermal atmospheric plasma treatment
A compound of non-thermal atmospheric plasma and medium is used to treat the target by direct application or by on-site generation of the compound
|
A compound of non-thermal, atmospheric plasma and medium is delivered to or generated at the target area.
Plasma is generated using either microsecond dielectric barrier discharge plasma device or PiezoBrush (a helium jet plasma).
The medium is an aqueous alcohol solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical improvement
Time Frame: 1-12 months
|
The outcome is the presence or lack of clinical improvement in the investigator's global assessment and reviewing photo-documentation as well as reflectance confocal microscopy study investigator's global assessment and reviewing photo-documentation
|
1-12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Anticipated)
March 1, 2024
Study Completion (Anticipated)
January 1, 2025
Study Registration Dates
First Submitted
April 26, 2016
First Submitted That Met QC Criteria
May 2, 2016
First Posted (Estimate)
May 3, 2016
Study Record Updates
Last Update Posted (Actual)
April 12, 2022
Last Update Submitted That Met QC Criteria
April 10, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Virus Diseases
- Infections
- Neoplasms by Histologic Type
- Neoplasms
- Carcinoma
- Neoplasms, Glandular and Epithelial
- DNA Virus Infections
- Skin Diseases, Infectious
- Skin Diseases, Viral
- Precancerous Conditions
- Neoplasms, Squamous Cell
- Carcinoma, Squamous Cell
- Poxviridae Infections
- Rosacea
- Keratosis, Actinic
- Keratosis
- Skin Diseases
- Bowen's Disease
- Molluscum Contagiosum
Other Study ID Numbers
- 20130084
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Warts
-
RXi Pharmaceuticals, Corp.UnknownPlantar Warts | Common Warts | HPV (Human Papillomavirus) | Periungual WartsUnited States
-
Maruho Co., Ltd.CompletedCutaneous Common WartsUnited States
-
Maruho Co., Ltd.CompletedCutaneous Common WartsUnited States
-
Karo Pharma ABCompletedPlantar Wart | Common WartPoland
-
Nielsen BioSciences, Inc.Recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingPalmar or Plantar WartsFrance
-
Swiss Footcare Laboratories - Poderm ProfessionalRecruitingWarts | Plantar Wart | Common WartTunisia
-
MediGeneCharité Research Organisation GmbHCompletedGenital Warts | Perianal WartsGermany
-
Novan, Inc.PPDCompletedGenital Warts | Perianal WartsUnited States
-
Combined Military Hospital AbbottabadCompletedCutaneous WartsPakistan
Clinical Trials on Non-thermal, atmospheric plasma to treat skin lesions and acne
-
Medical University of South CarolinaThe Skin Center Dermatology GroupRecruitingVerruca Vulgaris | Molluscum ContagiosumUnited States
-
Medical University of South CarolinaThe Skin Center Dermatology GroupCompletedVerruca Vulgaris | Molluscum Contagiosum Skin InfectionUnited States